Literature DB >> 10210776

Duration of STAT5 activation influences the response of interleukin-2 receptor alpha gene to different cytokines.

V Imbert1, P R Renauld.   

Abstract

Cytokines and growth factors regulate expression of their target genes via the Janus kinase (Jak)/signal transducers and activators of transcription (STAT) signaling pathway. One of the best characterized targets of STAT is the interleukin-2 receptor-alpha (IL-2Ralpha) gene. Its transcription is controlled by interleukin 2 (IL-2) through STAT5 activation. Using the PC60 cell line, in which the role of STAT5 in the regulation of the murine IL-2Ralpha gene by IL-2 has been elucidated, we have compared the response of this gene to IL-2, interleukin-9 (IL-9) and erythropoietin (Epo). IL-2 and IL-9, but not Epo, stimulate cell surface expression of IL-2Ralpha. This correlates with the fact that IL-2 and IL-9 support long-term STAT5 activation whereas Epo only induces transient activation. In cells treated with vanadate, a protein tyrosine phosphatase (PTP) inhibitor, Epo induces prolonged STAT5 activation and strongly stimulates IL-2Ralpha expression. Our study suggests that by controlling the duration of the STAT activation signal, PTP influences the specificity of cytokine signaling.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10210776

Source DB:  PubMed          Journal:  Eur Cytokine Netw        ISSN: 1148-5493            Impact factor:   2.737


  4 in total

1.  Interleukin 9 induces expression of three cytokine signal inhibitors: cytokine-inducible SH2-containing protein, suppressor of cytokine signalling (SOCS)-2 and SOCS-3, but only SOCS-3 overexpression suppresses interleukin 9 signalling.

Authors:  D Lejeune; J B Demoulin; J C Renauld
Journal:  Biochem J       Date:  2001-01-01       Impact factor: 3.857

2.  Time-Dependent Regulation of IL-2R α-Chain (CD25) Expression by TCR Signal Strength and IL-2-Induced STAT5 Signaling in Activated Human Blood T Lymphocytes.

Authors:  Alla N Shatrova; Elena V Mityushova; Irina O Vassilieva; Nikolay D Aksenov; Valery V Zenin; Nikolay N Nikolsky; Irina I Marakhova
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

Review 3.  An Update on Interleukin-9: From Its Cellular Source and Signal Transduction to Its Role in Immunopathogenesis.

Authors:  Sushmita Chakraborty; Katharina F Kubatzky; Dipendra Kumar Mitra
Journal:  Int J Mol Sci       Date:  2019-04-29       Impact factor: 5.923

Review 4.  Interleukin (IL)-9 Supports the Tumor-Promoting Environment of Chronic Lymphocytic Leukemia.

Authors:  Laura Patrussi; Nagaja Capitani; Cosima T Baldari
Journal:  Cancers (Basel)       Date:  2021-12-15       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.